98%
921
2 minutes
20
Purpose: While the scala tympani (ST) is usually the preferred site for electrode insertion in cochlear implantation, anatomical variations and cochlear ossification may require scala vestibuli (SV) insertion. This systematic review evaluates the feasibility, techniques, and clinical outcomes of SV insertions compared to ST insertions, focusing on their impact on auditory performance.
Methods: A systematic review was conducted using PRISMA guidelines. Studies on SV cochlear implantation were identified from databases like PubMed and EMBASE. The review included research articles reporting on anatomical feasibility, surgical methods, postoperative outcomes, and complications. Data extraction focused on demographic details, electrode types, insertion depths, and clinical outcomes of SV insertions. A two-stage selection process was applied, and 17 studies with 72 cases were included.
Results: The review covered 72 cases of SV insertions, with patients aged 18 months to 65 years. Bacterial meningitis was the leading cause of hearing loss (28%). Various electrode types were used, with insertion depths ranging from 12 to 31 mm. Approximately 75% of patients showed improved auditory performance. Complications, including vertigo and tinnitus, were reported in 10% of cases, with no significant difference between SV and ST insertions.
Conclusion: SV cochlear implantation is a feasible and effective alternative in cases where ST is inaccessible. Auditory outcomes are comparable to ST insertions, and the technique shows promise in challenging anatomical situations such as cochlear ossification. Further studies are required to optimize surgical approaches and confirm long-term outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00405-024-09095-w | DOI Listing |
Hum Genet
September 2025
College of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Chinese PLA Medical School, 28 Fuxing Road, Beijing, 100853, China.
Recessive variants in TWNK cause syndromes arising from mitochondrial DNA (mtDNA) depletion. Hearing loss is the most prevalent manifestation in individuals with these disorders. However, the clinical and pathophysiological features have not been fully elucidated.
View Article and Find Full Text PDFBraz J Otorhinolaryngol
September 2025
Clinical Research Department, MED-EL GmbH, Innsbruck, Austria.
Objectives: Healthcare systems contribute significantly to global greenhouse gas emissions through energy consumption and waste generation. This study aims to explore strategies to make cochlear implantation processes more environmentally sustainable and aligned with the United Nations' Sustainable Development Goals.
Methods: We examined various approaches including the use of bio-based and biodegradable materials, sustainable energy solutions, greener anesthetic practices, effective waste separation and recycling in operating rooms, and patient-centered strategies such as reducing travel and promoting early activation and fitting of cochlear implants.
Am J Case Rep
September 2025
Oto-Rhino-Laryngology Surgery Clinic, Institute of Physiology and Pathology of Hearing - World Hearing Center, Kajetany, Poland.
BACKGROUND Duplicated internal auditory canal (dIAC) is a rare congenital temporal bone anomaly associated with ipsilateral sensorineural hearing loss (SNHL). The Bonebridge bone conduction implant has a magnet, an internal transducer, and an external audio processor. This report is of a 14-year-old girl with unilateral SNHL and vestibulocochlear nerve (VIII cranial nerve) aplasia due to dIAC who was treated with a Bonebridge bone conduction implant.
View Article and Find Full Text PDFObjective: This study aims to evaluate long-term auditory outcomes in patients with inner ear malformations (IEMs) treated with cochlear or auditory brainstem implants (CI/ABI), and to assess the influence of anatomical subtype, electrode design, insertion depth, and genetic/syndromic background on hearing performance over a 10-year follow-up.
Methods: We conducted a prospective cohort study including patients with radiologically confirmed IEMs and bilateral severe-to-profound hearing loss, all of whom underwent implantation and completed at least 10 years of follow-up. Outcomes were assessed using pure-tone average (PTA) and speech recognition scores (SRS) at defined intervals.
Curr Opin Otolaryngol Head Neck Surg
October 2025
Department of Otolaryngology Head and Neck Surgery, University of Vienna, Vienna, Austria.
Purpose Of Review: The recent successful otoferlin gene therapy trials have refocused the fields attention on the potential of gene therapy to cure hearing loss. With over 100 known monogenetic causes of hearing loss, the key question is which will be the next set of disorders that are treatable. The current review addresses potentially targetable hearing disorders that can be addressed with current gene therapy technologies.
View Article and Find Full Text PDF